TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) Director James R. Tobin sold 10,000 shares of TransMedics Group stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $70.14, for a total transaction of $701,400.00. Following the sale, the director now owns 233,591 shares of the company’s stock, […]
Oppenheimer & Co. Inc. acquired a new stake in TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) in the first quarter, Holdings Channel reports. The fund acquired 9,540 shares of the company’s stock, valued at approximately $257,000. Other institutional investors have also recently bought and sold shares of the company. Ensign Peak Advisors Inc bought a […]
Shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) have been assigned a consensus rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […]
Globus Medical, Inc. (NYSE:GMED – Get Rating) has been assigned an average recommendation of “Buy” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 1,730,000 shares, an increase of 55.9% from the April 30th total of 1,110,000 shares. Based on an average daily trading volume, of 296,200 shares, […]